iShares China Large-Cap ETF vs InMode Ltd — how do they compare? iShares China Large-Cap ETF trades at $34.27 (market cap $3.86B), while InMode Ltd trades at $14.22 (market cap $809.93M). The key difference: iShares China Large-Cap ETF is far larger — about 4.8× InMode Ltd's market cap, and InMode Ltd is more actively traded (365,490 versus 16,323,837). Which is the better fit depends on your goals — on Pluang, investors hold iShares China Large-Cap ETF for 150 Days and InMode Ltd for 28 Days on average.
| FXI | INMD | |
|---|---|---|
Market Cap | $3.86B | $809.93M |
Volume | 16,323,837 | 365,490 |
52-Week High | $41.08 | $16.62 |
52-Week Low | $31.59 | $12.76 |
Typical Hold Time | 150 Days | 28 Days |
Sector | — | Health |
Enterprise Value | — | $313.27M |
Signals from Pluang's Aura AI — not financial advice
FXI trades at $34.25, up 2.48% today but facing significant technical headwinds with a bearish overall signal. The ETF shows compelling valuation metrics with a P/E ratio of 11.10 versus the S&P 500's 22.54, offering potential value for investors seeking China exposure. Recent developments include the Trump-Xi summit in late September 2026, which may provide incremental risk reduction in U.S.-China relations.
The outlook remains cautious due to China's economic challenges including industrial overcapacity and weak domestic consumption. While the valuation discount presents opportunity, geopolitical risks and technical weakness suggest limited near-term upside. Key catalysts include China's monetary policy stance and progress on trade relations with the U.S.
InMode (INMD) trades at $14.21, up 1.43% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong fundamentals with a P/E of 11.63, gross margins of 76.52%, and consistent profitability. Recent Q2 2026 earnings beat expectations with $95.6M revenue, while facing shareholder activism from Steel Partners' $16.75 per share acquisition offer.
Investment outlook remains cautious with analyst consensus divided (45% Buy, 55% Hold) amid cyclical industry softness. Key opportunities include international growth and new product launches like Morpheus8 Cool, while risks involve US sales declines and capital allocation concerns. The stock presents value characteristics but requires monitoring of management's strategic response to acquisition pressure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →